NORWAY |OL |NOK
|Public Float||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||54.78%||Ex-Dividend Date|
|Held by Institutions||-||IPO Date||-|
|Dec 21||Dec 20||Dec 19|
|Mar 22||Dec 21||Sep 21|
Lytix biopharma as trades on the Oslo stock market in Norway under the ticker symbol "LYTIX". Lytix biopharma as’s stock symbol can also be displayed as "OSE:LYTIX".
Lytix biopharma as (OSE:LYTIX) is owned by 0.00% institutional shareholders and by 54.78% insiders. The rest is owned by the public.
Explore More Details on Lytix biopharma as's “Ownership” Section
Lytix biopharma as's key executive team includes the following managers:
Lytix biopharma as (OSE:LYTIX) is classified under the "Healthcare" sector and under the "Biotechnology" industry.
Currently the number of employees working for Lytix biopharma as is 8.
Lytix biopharma as (OSE:LYTIX) is headquartered in Norway.
Lytix biopharma as’s mailing address is Sandakerveien 138, Oslo, Norway, 0484.
The company’s phone number is 47 95 26 05 12.